El dolor no tratado en los países de renta baja y media

El 83% de la población mundial tiene un acceso escaso o nulo a la morfina y a otros medicamentos controlados para fines médicos.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

More than 5.5 billion people (83% of the world’s population) in over 150 countries have low to non-existent access to morphine and other controlled medicines for pain relief, palliative care or opioid dependency.

Although access to morphine has increased exponentially over the last two decades, global inequalities in access to pain relief are stark. Ninety per cent of the global consumption of morphine, fentanyl and oxycodone registered in 2009 occurred in Australia, Canada, New Zealand, the United States and several European countries (See Map below). All these medicines are ‘scheduled’ and controlled under the UN 1961 Single Convention on Narcotic Drugs. Widespread lack of access in lower and middle-income countries (LMICs), however, underlines the serious limitations of the current regulatory regime.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.